Pharmaceutical Industry Reports Non-Small Cell Lung Cancer Market | Page 2

REPORT DESCRIPTION
Non-Small Cell Lung Cancer Market – Overview
Cancer is the disease in which cell grows abnormally and may cause a tumor. In lung cancer, the cells of lungs
starts to grow in uncontrolled manner later form a tumor and can be spread into other body parts. Small cell lung
cancer and non-small cell lung cancer are the two main types of lung cancer. As per the stats of Lung Cancer
Alliance (leading nonprofit organization dedicated to fighting lung cancer), out of overall lung cancer, around 80
to 85% cases found are of non-small cell lung cancer type and 15-20% cases found are of small cell lung cancer
type.
The different, commonly diagnosed types of non-small cell lung cancer (NSCLC) are adenocarcinoma, squamous
cell carcinoma, large cell carcinoma, large cell neuroendocrine tumors. Out of all these types adenocarcinoma and
squamous cell carcinoma accounts around 60% of lung cancer.
Some diagnosis test are performed by doctors to detect the lung cancer includes diagnostic imaging test like X-
ray, MRI, Ultrasound, CT scan and PET scan, also by checking the mucous when the patient cough up for cancer
cells which is called as sputum cytology or also by taking the cells of your lungs from abnormal growth area of
your lung or from the fluid of lungs which is called as fine needle aspiration biopsy, bronchoscopy and
Mediastinoscopy.